Currently the entire cannabinoid industry is in a downturn. The sky high valuations that these companies have been commanding past few months have clashed with reality, leaving investors scrambling for cover.
The whole premise for the high valuations was the high growth rate. However, as recent events in Canada show, legitimate cannabinoid companies still cannot...